Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.410
+0.070 (2.10%)
At close: Apr 7, 2026, 4:00 PM EDT
3.540
+0.130 (3.81%)
After-hours: Apr 7, 2026, 7:58 PM EDT

Prime Medicine Revenue

In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. Prime Medicine had revenue of $838.00K in the quarter ending December 31, 2025, a decrease of -61.61%.

Revenue (ttm)
$4.63M
Revenue Growth
+55.28%
P/S Ratio
130.36
Revenue / Employee
$31,726
Employees
146
Market Cap
603.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group418.63M
CorMedix311.71M
Valneva SE205.07M
Zevra Therapeutics106.47M
Aclaris Therapeutics7.83M
Ocugen4.41M
ProKidney893.00K
Allogene Therapeutics22.00K
Revenue Rankings